Department of Orthopedic Surgery, Kurume University Hospital, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan.
Department of Orthopedic Surgery, Kurume University Medical Center, 155-1 Kokubu-machi, Kurume, Fukuoka, 839-0863, Japan.
J Orthop Surg Res. 2020 Jun 3;15(1):204. doi: 10.1186/s13018-020-01715-5.
Arthroscopic rotator cuff repair (ARCR) generally yields acceptable clinical results. Hyaluronic acid (HA), a high-molecular-weight polysaccharide, is present in the extracellular matrix of soft connective tissue and synovial fluid, and its injection is known to significantly improve pain and clinical outcomes after rotator cuff injury. Some studies have described the role of HA injections as conservative therapy for rotator cuff tears. Since the subacromial bursa is believed to be the main source of shoulder pain in rotator cuff tears, subacromial injection is frequently used before surgery; however, its relationship with the clinical outcome after surgery remains unclarified. Therefore, we aimed to examine effects of preoperative subacromial HA injection on postoperative clinical outcome in patients with ARCR.
Ninety-eight patients were divided into a HA injection group and a non-injection group. The functional outcome measured was the University of California, Los Angeles (UCLA) score. Univariate analysis was performed to obtain variables with p values less than 0.1; we then used propensity score analysis, adjusting for pre- and post-operative confounding factors.
The UCLA scores of all patients significantly improved 1 year postoperatively (PO) (p < 0.05). Subacromial HA injections were performed in patients with worse preoperative function. Univariate analysis showed significantly greater improvements in the injection group than in the non-injection group in terms of preoperative UCLA score, trauma, diabetes mellitus, UCLA score 3 months PO, abduction strength 4 months PO, and internal rotation (IR) strength 6 and 12 months PO. Propensity score analysis demonstrated that UCLA scores 3 months PO and IR strength 12 months PO in the injection group were significantly greater than those in the non-injection group. There were no significant differences in postoperative re-tear rates between the groups. In sub-analysis of the injection group, propensity scores showed that concurrent use of local anesthetics did not affect the data, suggesting that HA was effective.
Subacromial injection was administered to patients with worse function before ARCR. Propensity score analysis successfully demonstrated that functional outcome after surgery was improved in patients who were administered this injection compared with patients who were not administered this injection before surgery.
关节镜下肩袖修复术(ARCR)通常可获得可接受的临床效果。透明质酸(HA)是一种高分子量多糖,存在于软结缔组织和滑液的细胞外基质中,其注射已被证实可显著改善肩袖损伤后的疼痛和临床结果。一些研究描述了 HA 注射作为肩袖撕裂的保守治疗。由于肩峰下囊被认为是肩袖撕裂引起肩部疼痛的主要来源,因此在手术前经常进行肩峰下注射;然而,其与手术后临床结果的关系尚不清楚。因此,我们旨在研究 ARCR 术前肩峰下 HA 注射对术后临床结果的影响。
98 例患者分为 HA 注射组和非注射组。测量的功能结果是加利福尼亚大学洛杉矶分校(UCLA)评分。进行单变量分析以获得 p 值小于 0.1 的变量;然后使用倾向评分分析,调整术前和术后混杂因素。
所有患者的 UCLA 评分在术后 1 年均显著提高(p<0.05)。肩峰下 HA 注射用于术前功能较差的患者。单变量分析显示,在术前 UCLA 评分、创伤、糖尿病、术后 3 个月 UCLA 评分、术后 4 个月外展力量、术后 6 和 12 个月内旋(IR)力量方面,注射组的改善明显大于非注射组。倾向评分分析表明,注射组术后 3 个月 UCLA 评分和术后 12 个月 IR 力量明显大于非注射组。两组术后再撕裂率无显著差异。在注射组的亚分析中,倾向评分表明局部麻醉剂的同时使用并未影响数据,表明 HA 是有效的。
ARCR 前向肩峰下注射用于功能较差的患者。倾向评分分析成功表明,与未接受术前注射的患者相比,接受该注射的患者手术后的功能恢复更好。